Asia Pacific Nasal Delivery Devices Market
The Asia Pacific Nasal Delivery Devices Market size was valued at US$ 12,418.34 Mn in 2019 and is projected to reach US$ 21,402.86 Mn by 2027, growing at a CAGR of 7.1% during 2020 - 2027.
Report Coverage
- Drug Type: Anaesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, Antihistamines
- Delivery Technologies: Spray, Nebulizers, Inhalers
- End User: Home Care Settings, Hospitals, Clinics
US$ 12,418.34 Mn
Market size in 2019
US$ 21,402.86 Mn
Market Size by 2027
7.1%
CAGR, 2020 - 2027
2020-2027
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Nasal Delivery Devices Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Nasal Delivery Devices Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Nasal Delivery Devices Market Regional Analysis
6.2 Asia Pacific Nasal Delivery Devices Market Revenue 2017-2027 (US$ Million)
6.3 Asia Pacific Nasal Delivery Devices Market Forecast Analysis
7. Asia Pacific Nasal Delivery Devices Market Analysis – by Drug Type
7.1 Anaesthetics
- 7.1.1 Overview
- 7.1.2 Anaesthetics: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Antibiotics
- 7.2.1 Overview
- 7.2.2 Antibiotics: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Pain Relief Drugs
- 7.3.1 Overview
- 7.3.2 Pain Relief Drugs: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Calcium Supplements
- 7.4.1 Overview
- 7.4.2 Calcium Supplements: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Vasoconstrictors
- 7.5.1 Overview
- 7.5.2 Vasoconstrictors: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.6 Antihistamines
- 7.6.1 Overview
- 7.6.2 Antihistamines: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Asia Pacific Nasal Delivery Devices Market Analysis – by Delivery Technologies
8.1 Spray
- 8.1.1 Overview
- 8.1.2 Spray: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Nebulizers
- 8.2.1 Overview
- 8.2.2 Nebulizers: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Inhalers
- 8.3.1 Overview
- 8.3.2 Inhalers: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Asia Pacific Nasal Delivery Devices Market Analysis – by End User
9.1 Home Care Settings
- 9.1.1 Overview
- 9.1.2 Home Care Settings: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Hospitals
- 9.2.1 Overview
- 9.2.2 Hospitals: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Clinics
- 9.3.1 Overview
- 9.3.2 Clinics: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. Asia Pacific Nasal Delivery Devices Market – Asia-Pacific Analysis
10.1 Overview
10.2 Asia-Pacific- 10.2.1 Asia Pacific Nasal Delivery Devices Market Breakdown, by Key Country, 2020 and 2027 (%)
- 10.2.1.1 Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 China: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 China: Asia Pacific Nasal Delivery Devices Market Breakdown, by Drug Type
- 10.2.1.1.2 China: Asia Pacific Nasal Delivery Devices Market Breakdown, by Delivery Technologies
- 10.2.1.1.3 China: Asia Pacific Nasal Delivery Devices Market Breakdown, by End User
- 10.2.1.2 India: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 India: Asia Pacific Nasal Delivery Devices Market Breakdown, by Drug Type
- 10.2.1.2.2 India: Asia Pacific Nasal Delivery Devices Market Breakdown, by Delivery Technologies
- 10.2.1.2.3 India: Asia Pacific Nasal Delivery Devices Market Breakdown, by End User
- 10.2.1.3 Japan: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Japan: Asia Pacific Nasal Delivery Devices Market Breakdown, by Drug Type
- 10.2.1.3.2 Japan: Asia Pacific Nasal Delivery Devices Market Breakdown, by Delivery Technologies
- 10.2.1.3.3 Japan: Asia Pacific Nasal Delivery Devices Market Breakdown, by End User
- 10.2.1.4 Australia: Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.4.1 Australia: Asia Pacific Nasal Delivery Devices Market Breakdown, by Drug Type
- 10.2.1.4.2 Australia: Asia Pacific Nasal Delivery Devices Market Breakdown, by Delivery Technologies
- 10.2.1.4.3 Australia: Asia Pacific Nasal Delivery Devices Market Breakdown, by End User
- 10.2.1.5 Rest of Asia-Pacific : Asia Pacific Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Nasal Delivery Devices Market Breakdown, by Drug Type
- 10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Nasal Delivery Devices Market Breakdown, by Delivery Technologies
- 10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Nasal Delivery Devices Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 GlaxoSmithKline plc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 AstraZeneca
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Pfizer Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 BD
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Sanofi
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Merck & Co., Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Cadila Pharmaceuticals Ltd.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Novartis AG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Dr. Reddy's Laboratories
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full A Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
